InnovAge (INNV) Competitors $2.75 -0.09 (-3.17%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$2.74 -0.01 (-0.36%) As of 04/17/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock INNV vs. NHC, PACS, TDOC, AHCO, VRDN, CDNA, AVAH, PNTG, GRAL, and FLGTShould you be buying InnovAge stock or one of its competitors? The main competitors of InnovAge include National HealthCare (NHC), PACS Group (PACS), Teladoc Health (TDOC), AdaptHealth (AHCO), Viridian Therapeutics (VRDN), CareDx (CDNA), Aveanna Healthcare (AVAH), The Pennant Group (PNTG), Grail (GRAL), and Fulgent Genetics (FLGT). These companies are all part of the "healthcare" industry. InnovAge vs. National HealthCare PACS Group Teladoc Health AdaptHealth Viridian Therapeutics CareDx Aveanna Healthcare The Pennant Group Grail Fulgent Genetics InnovAge (NASDAQ:INNV) and National HealthCare (NYSE:NHC) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, analyst recommendations, earnings, profitability, dividends, valuation and community ranking. Do institutionals and insiders hold more shares of INNV or NHC? 12.3% of InnovAge shares are owned by institutional investors. Comparatively, 56.4% of National HealthCare shares are owned by institutional investors. 1.4% of InnovAge shares are owned by company insiders. Comparatively, 15.0% of National HealthCare shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Does the media refer more to INNV or NHC? In the previous week, National HealthCare had 2 more articles in the media than InnovAge. MarketBeat recorded 5 mentions for National HealthCare and 3 mentions for InnovAge. National HealthCare's average media sentiment score of 1.37 beat InnovAge's score of 0.33 indicating that National HealthCare is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment InnovAge 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral National HealthCare 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility and risk, INNV or NHC? InnovAge has a beta of 0.41, indicating that its stock price is 59% less volatile than the S&P 500. Comparatively, National HealthCare has a beta of 0.42, indicating that its stock price is 58% less volatile than the S&P 500. Do analysts rate INNV or NHC? InnovAge presently has a consensus target price of $5.00, indicating a potential upside of 81.82%. Given InnovAge's stronger consensus rating and higher possible upside, equities analysts clearly believe InnovAge is more favorable than National HealthCare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score InnovAge 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50National HealthCare 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is INNV or NHC more profitable? National HealthCare has a net margin of 10.03% compared to InnovAge's net margin of -3.19%. National HealthCare's return on equity of 6.87% beat InnovAge's return on equity.Company Net Margins Return on Equity Return on Assets InnovAge-3.19% -9.45% -4.84% National HealthCare 10.03%6.87%4.68% Does the MarketBeat Community prefer INNV or NHC? National HealthCare received 3 more outperform votes than InnovAge when rated by MarketBeat users. Likewise, 100.00% of users gave National HealthCare an outperform vote while only 0.00% of users gave InnovAge an outperform vote. CompanyUnderperformOutperformInnovAgeOutperform VotesNo VotesUnderperform Votes5100.00% National HealthCareOutperform Votes3100.00% Underperform VotesNo Votes Which has stronger valuation & earnings, INNV or NHC? National HealthCare has higher revenue and earnings than InnovAge. InnovAge is trading at a lower price-to-earnings ratio than National HealthCare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInnovAge$806.61M0.46-$21.34M-$0.19-14.47National HealthCare$1.30B1.10$66.80M$6.5414.09 SummaryNational HealthCare beats InnovAge on 15 of the 17 factors compared between the two stocks. Get InnovAge News Delivered to You Automatically Sign up to receive the latest news and ratings for INNV and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INNV vs. The Competition Export to ExcelMetricInnovAgeHealth services IndustryMedical SectorNASDAQ ExchangeMarket Cap$371.92M$875.02M$5.30B$7.34BDividend YieldN/A2.59%5.45%4.30%P/E Ratio-14.4749.7121.8617.80Price / Sales0.467.23380.5497.74Price / CashN/A26.1438.2634.64Price / Book1.454.226.453.98Net Income-$21.34M-$5.50M$3.22B$247.81M1 Month Performance-20.52%1.34%-9.71%-7.84%1 Year Performance-30.38%68.44%11.51%1.60% InnovAge Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INNVInnovAge1.5748 of 5 stars$2.75-3.2%$5.00+81.8%-31.3%$371.92M$806.61M-14.472,000Short Interest ↓News CoverageNHCNational HealthCareN/A$92.33+0.5%N/AN/A$1.43B$1.30B11.5712,400News CoveragePositive NewsPACSPACS Group3.2413 of 5 stars$9.33+1.9%$34.00+264.4%-59.8%$1.42B$3.56B0.0032,433TDOCTeladoc Health3.752 of 5 stars$7.25flat$10.94+50.9%-48.2%$1.27B$2.57B-1.265,100Short Interest ↓AHCOAdaptHealth3.6732 of 5 stars$8.22-5.1%$13.80+67.9%-16.8%$1.11B$3.26B-4.9810,900VRDNViridian Therapeutics1.1715 of 5 stars$13.30+10.6%$35.70+168.4%-13.4%$1.08B$302,000.00-3.0950News CoveragePositive NewsCDNACareDx3.6689 of 5 stars$18.90+0.5%$31.83+68.4%+118.3%$1.05B$333.79M-7.00740Analyst ForecastPositive NewsGap UpAVAHAveanna Healthcare0.888 of 5 stars$4.71+4.9%$5.00+6.2%+110.2%$918.89M$2.02B-13.8533,000News CoverageGap DownPNTGThe Pennant Group3.3011 of 5 stars$26.03+2.6%$34.80+33.7%+31.4%$903.81M$695.24M38.285,340Positive NewsGRALGrail0.777 of 5 stars$24.85+6.8%$20.00-19.5%N/A$842.29M$125.60M0.001,360Short Interest ↑News CoveragePositive NewsFLGTFulgent Genetics3.5338 of 5 stars$18.95-0.3%$16.00-15.6%-11.2%$584.91M$283.47M-3.431,010Positive News Related Companies and Tools Related Companies NHC Competitors PACS Competitors TDOC Competitors AHCO Competitors VRDN Competitors CDNA Competitors AVAH Competitors PNTG Competitors GRAL Competitors FLGT Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:INNV) was last updated on 4/19/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InnovAge Holding Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share InnovAge With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
